A recent optical mapping study employed dual Ca2+/Vm monitoring in heterozygous RyR2-R2474S CPVT hearts and similarly found no change in overall CV [36]. The gene discussed is RYR2; the disease is catecholaminergic polymorphic ventricular tachycardia.